Trial Profile
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Oct 2013 Planned end date changed from 1 Sep 2013 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 11 Feb 2013 New trial record